ResMed 配当と自社株買い
配当金 基準チェック /46
ResMedは配当を支払う会社で、現在の利回りは0.89%ですが、利益によって十分にカバーされています。次の支払い日は 12th December, 2024で、権利落ち日は7th November, 2024 。
主要情報
0.9%
配当利回り
0.4%
バイバック利回り
| 総株主利回り | 1.3% |
| 将来の配当利回り | 1.1% |
| 配当成長 | -11.2% |
| 次回配当支払日 | 12 Dec 24 |
| 配当落ち日 | 07 Nov 24 |
| 一株当たり配当金 | US$2.120 |
| 配当性向 | 26% |
最近の配当と自社株買いの更新
Recent updates
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why
Nov 13
We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease
Nov 01Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Oct 20ResMed Inc.'s (NYSE:RMD) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 08Why ResMed's Rally Is Just Getting Started
Sep 18ResMed Inc.'s (NYSE:RMD) Earnings Haven't Escaped The Attention Of Investors
Sep 13ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26決済の安定と成長
配当データの取得
安定した配当: RMDの1株当たり配当金は過去10年間安定しています。
増加する配当: RMDの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| ResMed 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (RMD) | 0.9% |
| 市場下位25% (US) | 1.4% |
| 市場トップ25% (US) | 4.3% |
| 業界平均 (Medical Equipment) | 1.6% |
| アナリスト予想 (RMD) (最長3年) | 1.1% |
注目すべき配当: RMDの配当金 ( 0.89% ) はUS市場の配当金支払者の下位 25% ( 1.39% ) と比べると目立ったものではありません。
高配当: RMDの配当金 ( 0.89% ) はUS市場の配当金支払者の上位 25% ( 4.32% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: RMDの 配当性向 ( 26% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: RMDは低い 現金配当性向 ( 23.1% ) であるため、配当金の支払いはキャッシュフローによって十分にカバーされています。